Previous Article | Next Article 
Applied and Environmental Microbiology, April 1999, p. 1470-1476, Vol. 65, No. 4
0099-2240/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Identification of Aerobically and Anaerobically Induced Genes
in Enterococcus faecalis by Random Arbitrarily
Primed PCR
Brett D.
Shepard1 and
Michael S.
Gilmore1,2,*
Department of Microbiology and
Immunology1 and Department of
Ophthalmology,2 University of Oklahoma
Health Sciences Center, Oklahoma City, Oklahoma 73104
Received 16 October 1998/Accepted 19 January 1999
 |
ABSTRACT |
Enterococci have emerged among the leading causes of nosocomial
infection. With the goal of analyzing enterococcal genes differentially expressed in environments related to commensal or environmental colonization and infection sites, we adapted and optimized a method more commonly used in the study of eukaryotic gene expression, random
arbitrarily primed PCR (RAP-PCR). The RAP-PCR method was systematically
optimized, allowing the technique to be used in a highly reproducible
manner with gram-positive bacterial RNA. In the present study,
aerobiosis was chosen as a variable for the induction of changes in
gene expression by Enterococcus faecalis. Aerobically and
anaerobically induced genes were detected and identified to the
sequence level, and differential gene expression was confirmed by
quantitative, specifically primed RT-PCR. Differentially expressed
genes included several sharing identity with those of other organisms
related to oxygen metabolism, as well as hypothetical genes lacking
identity to known genes.
 |
INTRODUCTION |
Enterococci have emerged as leading
causes of nosocomial infection, including urinary tract infections,
wound infections, and bacteremia (10, 12, 25, 33, 37, 39, 41,
44). Among these and other types of enterococcal infection,
approximately 80% are associated with Enterococcus faecalis
(21) and the majority are nosocomial (34).
Enterococcal infections are especially troublesome because of the high
level of intrinsic antibiotic resistance and because they have acquired
resistance determinants capable of rendering the organism completely
resistant to all currently approved antibiotics (21).
Because of the emergence of enterococci as leading nosocomial pathogens
and the development of broad antimicrobial resistance, particularly to
vancomycin, an understanding of host-parasite interactions is a key to
the development of new prophylactic and therapeutic strategies. Only a
few traits are known to contribute to the pathogenesis of enterococcal
infection. The enterococcal cytolysin contributes to toxicity, loss of
organ function, and lethality during enterococcal infection (6,
24, 26), and cytolytic strains of E. faecalis have
been observed to be enriched among clinical isolates, especially those
from the bloodstream (21-23). Enterococcal aggregation
substance has been demonstrated to contribute to increased cardiac
vegetation size (6) and has been associated with enhanced
virulence in a rabbit model of endocarditis (45). Other
putative virulence factors include surface carbohydrates (18,
19) and enterococcal lipoteichoic acid (2), but their
specific roles in enterococcal infection have yet to be determined.
Since enterococci evolved as commensal organisms, the contribution of
specific factors to pathogenesis is typically subtle. Thus, sensitive
techniques are required for the identification of such factors.
Differential-display PCR (DD-PCR) is a relatively new method for
observing the differential expression of genes in comparative studies
within a large number of experimental systems (31, 35, 51).
The technique was originally developed for use in the study of
eukaryotic gene expression, and this continues to be its most common
application (31, 35). A derivative of DD-PCR, random arbitrarily primed PCR (RAP-PCR), utilizes an arbitrary primer at a low
annealing temperature for both the first- and second-strand cDNA
synthesis reactions (51). At such low-stringency
temperatures the arbitrary primer is able to bind at random sites
within the template that show limited, but not complete,
complementarity. Because the same arbitrary primer is used as both the
5' and the 3' primers, the primer sequence is incorporated at both ends
of the resulting double-stranded products. The products are amplified by standard PCR by using the arbitrary primer, resolved by
polyacrylamide electrophoresis, and visualized by autoradiography.
Differences in gene expression can be inferred from the resulting
"fingerprint" by observing the presence or absence of specific
products between different populations of cells. By eliminating the use
of an oligo(dT) primer, the 3' bias toward the polyadenylate tail in
eukaryotic mRNA is eliminated. Thus, priming of first-strand synthesis
potentially can occur at any point within the RNA. For this reason,
RAP-PCR may be used for amplification of RNAs that are not
polyadenylated, such as bacterial RNA.
This technology has been applied to only a few prokaryotic systems
(1, 52) because of high sample-to-sample variability, as was
encountered in initial attempts to study E. faecalis gene expression by using available methods (51, 52). We therefore systematically optimized the RAP-PCR method and identified several key
refinements which ultimately allowed the technique to be used in a
highly reproducible manner with gram-positive bacterial RNA. In the
present study, aerobiosis was chosen as a variable for the induction of
changes in gene expression by E. faecalis. Aerobically and
anaerobically induced genes were detected and identified to the
sequence level, and differential gene expression was confirmed by
quantitative, specific reverse transcriptase PCR (RT-PCR).
 |
MATERIALS AND METHODS |
Bacterial strains and growth conditions.
A strain of
E. faecalis, MMH594 (23), that caused multiple
infections in a hospital ward outbreak was used to study differential gene expression under either aerobic or anaerobic conditions. Escherichia coli XL-1 Blue (Stratagene, La Jolla, Calif.)
was used for cloning differentially expressed RAP-PCR products. For aerobically cultured E. faecalis, a 10-ml overnight culture
was grown in a 50-ml centrifuge tube for 18 h in brain heart
infusion (BHI) broth (Becton Dickinson, Cockeysville, Md.) at 37°C
with shaking at 300 rpm. The overnight culture was diluted 1:100 in 10 ml of fresh BHI broth and subcultured in a 50-ml centrifuge tube to
mid-log phase (optical density at 560 nm [OD560] of 1.0) at 37°C with shaking at 300 rpm for 4 h prior to RNA isolation. For anaerobically cultured E. faecalis, a 10-ml overnight
culture was grown in a 50-ml centrifuge tube in BHI broth at 37°C
without shaking for 18 h in an anaerobic hood. The overnight
culture was diluted 1:100 in 10 ml of fresh BHI broth and subcultured
anaerobically in a 50-ml centrifuge tube to mid-log phase
(OD560 = 1.0) at 37°C without shaking for 3.5 h
prior to RNA isolation. E. coli was cultured on plates
containing Luria-Bertani (LB) media and 1.5% Bacto-Agar (Difco,
Detroit, Mich.), and appropriate transformants were subsequently
cultured in LB broth (43). Antibiotics used for selection of
transformed E. coli included ampicillin (100 µg/ml) and
tetracycline (12.5 µg/ml) (Sigma, St. Louis, Mo.). For detection of
insertional inactivation of the lacZ
gene contained in
the cloning vectors, 50 µM
isopropyl-
-D-thiogalactopyranoside (Sigma) and 0.01%
5-bromo-4-chloro-3-indolyl-
-D-galactopyranoside (Sigma)
were added to the media.
RNA extraction and preparation.
Total RNA was isolated as
previously described (5) with minor modifications. Briefly,
each 10-ml subculture of E. faecalis was centrifuged
(2,500 × g for 2 min at 4°C), and the bacterial pellet was resuspended in 1.5 ml of Tri Reagent (Sigma). The cell suspension was immediately transferred to a 2-ml microcentrifuge tube
(BioSpec Products, Bartlesville, Okla.) containing 0.5 ml of
100-µm-diameter zirconia-silica beads (BioSpec Products). The tube
was immediately placed in a high-speed reciprocating shaker (BioSpec
Products) and horizontally shaken at 5,000 rpm for 1 min to lyse the
bacterial cells. After lysis, the tube was placed on ice and the beads
were allowed to settle out of the lysis mixture. The lysate was
clarified by centrifugation (12,000 × g for 10 min at
4°C). The supernatant was recovered and extracted with 300 µl of
chloroform. After a manual shaking for 15 s, the mixture was
placed on ice for 15 min prior to centrifugation (12,000 × g for 10 min at 4°C). After centrifugation the aqueous phase was recovered, and the RNA was precipitated by adding 750 µl of isopropyl alcohol. After incubation on ice for 10 min, the RNA was pelleted by
centrifugation (12,000 × g for 10 min at 4°C). The
RNA pellet was washed with 1.7 ml of 75% ethanol, air dried for 5 to
10 min, and resuspended in 200 µl of diethylpyrocarbonate
(DEPC)-treated water.
Residual contaminating genomic DNA was removed in the following manner.
After resuspension of the total RNA, a 0.25 volume of
transcription-optimized buffer (Promega, Madison, Wis.) containing 200 mM Tris-HCl (pH 7.9), 30 mM MgCl2, 10 mM spermidine, and 50 mM NaCl was added. Five units of RQ1 RNase-free DNase (Promega) was
added, and the mixture was incubated at 37°C for 15 min. After incubation, 250 µl of phenol-water (3.75:1 [vol/vol]; Life
Technologies, Grand Island, N.Y.) was added. Additionally, 250 µl of
chloroform was added, and the solution was centrifuged
(12,000 × g for 10 min at 4°C). RNA was recovered in
the aqueous phase, and the phenolic phase was extracted with 250 µl
of TE buffer and centrifuged to ensure quantitative recovery. After
centrifugation, the second aqueous phase was recovered and mixed with
the first. RNA was precipitated by the addition of 1 ml of 100%
ethanol and incubation at
70°C for at least 30 min. RNA was
pelleted by centrifugation (12,000 × g for 20 min at
4°C), washed with 75% ethanol, and air dried for 5 to 10 min.
DNase-treated total RNA was resuspended in 50 µl of DEPC-treated
water containing 0.1 mM EDTA and stored at
70°C.
The integrity of the RNA was assessed by electrophoresis of 2 µl of
each sample through a 1.2% agarose-0.66 M formaldehyde gel in MOPS
running buffer (20 mM MOPS [morpholinepropanesulfonic acid; pH 7.0],
8 mM sodium acetate, 1 mM EDTA [pH 8.0]) at a power of 3 to 4 V/cm
(43). RNA concentration was determined
spectrophotometrically by measuring the
A260/A280 ratio of a 1:50 dilution
in DEPC-treated water.
RAP-PCR.
To initiate each experimental reaction, 14.5 µl
containing 1 µg of total E. faecalis RNA, diluted in
DEPC-treated water as needed, was heated in a 0.65-ml thin-wall PCR
tube to 70°C for 10 min and immediately placed on ice. After 1 min of
incubation on ice and brief centrifugation pulse to collect contents, 5 µl of buffer containing 50 mM Tris-HCl (pH 8.3), 75 mM KCl, 3 mM MgCl2, a 1.25 µM concentration of an arbitrarily chosen
primer (Stratagene), 1.25 mM concentrations of each deoxynucleoside
triphosphate (dNTP), and 40 U of RNase Block RNase inhibitor
(Stratagene) was added. Contents were mixed, collected by brief
centrifugation, and allowed to equilibrate to 37°C for 5 min. After
equilibration, 25 U of Moloney murine leukemia virus (MMLV) RT
(Stratagene) was added for a final volume of 20 µl. The reaction was
incubated at 37°C for 1 h. Upon completion of first-strand cDNA
synthesis, the reaction was heated to 90°C for 5 min to inactivate
the RT and then immediately placed on ice for 10 min. The reaction was diluted 1:10 in sterile water and either used immediately in a second-strand synthesis reaction or stored at
20°C.
For second-strand synthesis, 10 µl of the cDNA preparation was mixed
with 39.8 µl of a standard PCR mixture in a 0.65-ml thin-wall PCR
tube for a final reaction volume of 50 µl containing 10 mM Tris-HCl
(pH 9.0), 50 mM KCl, 3 mM MgCl2, 50 µM concentrations of
each dNTP, 10 µCi of [
-33P]dCTP (DuPont NEN, Boston,
Mass.), and a 1 µM concentration of the same arbitrary primer used in
first-strand cDNA synthesis. After overlay of 50 µl of light mineral
oil, the reaction was incubated at 96°C for 10 min, followed by
incubation at 36°C for 15 min. After the extended equilibration at
36°C, 1 U of Taq polymerase was added with gentle mixing
of contents. The reaction was allowed to equilibrate at 36°C for an
additional 15 min, followed by a 5-min incubation at 72°C. The
following parameters were used for an additional 39 cycles of PCR:
94°C (1 min), 50°C (1 min), 72°C (2 min), and a final extension
at 72°C for 10 min. Upon completion, the reaction was stored at 0 to
4°C. The sequences of the primers used in separate RAP-PCR
experiments were AATCTAGAGCTCTCCAGC (primer 1) and
AATCTAGAGCTCCCTCCA (primer 2).
To visualize RAP-PCR products, 5 µl from each reaction was mixed with
10 µl of stop buffer containing 80% formamide, 50 mM Tris-HCl (pH
8.3), 1 mM EDTA, 0.1% (wt/vol) xylene cyanol, and 0.1% (wt/vol)
bromophenol blue. The samples were heated to 96°C for 2 min, and the
contents were collected by brief centrifugation. Five microliters of
each reaction was loaded on a 6% polyacrylamide sequencing gel
prepared in TBE buffer (Life Technologies). Electrophoresis was
performed at 1,500 V and continued until the xylene cyanol dye had
migrated to 2.5 cm above the bottom of the gel. The gel was transferred
to 3MW paper (Midwest Scientific, Valley Park, Mo.) and dried under
vacuum at 80°C for 40 min. Autoradiography was performed by exposing
the gel to Kodak BioMax MR film for 18 h at an ambient temperature.
Isolation, cloning, and sequencing of RAP-PCR products.
The
RAP-PCR gel and the autoradiogram were aligned by using radioactive ink
marks placed on the gel prior to autoradiography. By using the
autoradiogram as a template, individual bands representing differentially expressed products were cut and removed from the gel
with a sterile scalpel (30, 52). Each isolated piece of acrylamide gel with filter paper was cut into smaller pieces with a
sterile scalpel, and the pieces were collected in a microcentrifuge tube. Fifty microliters of elution buffer (0.5 M ammonium acetate, 10 mM magnesium acetate, 1 mM EDTA [pH 8.0], 0.1% sodium dodecyl sulfate) (1, 43) was added to the tube, and the mixture was heated to 100°C for 30 min. The eluate from the reaction was
collected, and the DNA was precipitated by the addition of 0.1 volume
of 3 M sodium acetate (pH 5.17) and 2.5 volumes of 100% ethanol
followed by incubation at
70°C for 2 h. DNA was pelleted by
centrifugation at 12,000 × g for 30 min at 4°C. The
DNA pellet was washed with 2.5 volumes of 75% ethanol, air dried for 5 min, and resuspended in 10 µl of sterile water.
The individual products of interest were reamplified with the same
primer incorporated in both first- and second-strand synthesis reactions of RAP-PCR. The entire volume of recovered DNA was amplified in a standard 50-µl PCR mixture containing 10 mM Tris-HCl (pH 9.0),
50 mM KCl, 3 mM MgCl2, a 50 µM concentration of each
dNTP, a 1 µM concentration of the arbitrary primer, and 1 U of
Taq polymerase (Promega). The following parameters were used
in the PCR: 94°C (1 min), 50°C (1 min), 72°C (2 min), and a final
extension at 72°C for 10 min. The reamplified RAP-PCR products were
analyzed on a 1% low-melting-point agarose gel and purified using a
Geneclean kit (Bio 101, Vista, Calif.) according to the manufacturer's recommendations.
Each purified RAP-PCR product was ligated into either the
EcoRV site of the pBluescript cloning vector (Stratagene) or
the XcmI site of the pKRX cloning vector (46) by
standard techniques for blunt-end ligation (43). Ligation
products were used to transform E. coli XL-1 Blue
(Stratagene) according to established protocols (43).
Transformed E. coli were identified by using inactivation of
the lacZ
gene as a phenotypic marker (43), and
plasmids containing the RAP-PCR product of interest were isolated by
using the Wizard Plus Miniprep kit (Promega) according to the manufacturer's recommendations.
DNA sequence information was obtained by using standard chain
termination reactions employing fluorescein-labeled M13 forward and
reverse primers (Pharmacia Biotech, Piscataway, N.J.) and a T7 DNA
polymerase-based AutoRead Sequencing Kit (Pharmacia Biotech), with a
Pharmacia LKB A.L.F. DNA Sequencer. GCG utilities on a VAX mainframe
were used in BLAST searches for sequence homologies (49).
Confirmation of differential gene expression.
Sequence data
from each differentially expressed RAP-PCR product was used to develop
specific primers for use in specifically primed, quantitative RT-PCR to
confirm differential gene expression. In each reaction, 1 µg of total
RNA, diluted in DEPC-treated water as needed, was incubated at 85°C
for 3 min and immediately placed on ice. After a 1-min incubation on
ice and brief centrifugation to collect contents, 8 µl of a standard
RT-PCR reaction mixture was added in a final reaction volume of 20 µl
containing 10 mM Tris-HCl (pH 8.3), 50 mM KCl, 1.5 mM
MgCl2, 500 µM concentrations of each dNTP, 50 pmol of the
specific reverse primer, 10 U of RNase inhibitor (Ambion, Austin,
Tex.), and 100 U of MMLV RT (Ambion). After gentle mixing and brief
centrifugation, each reaction was incubated at 42°C for 60 min
followed by a 10-min incubation at 92°C. The cDNA from each reaction
was either used immediately in PCR or stored at
20°C.
For amplification, 5 µl of the cDNA preparation was mixed with 45 µl of a standard PCR mixture in a final reaction volume of 50 µl
containing 10 mM Tris-HCl (pH 8.3), 50 mM KCl, 1.5 mM MgCl2, 125 µM concentrations of each dNTP, 50 pmol each
of both the specific forward and reverse primers, and 5 U of
Taq polymerase (Promega). Each reaction was gently mixed and
overlaid with 50 µl of light mineral oil. After a 5-min incubation at
95°C, amplification was performed for 20 cycles by using the
following parameters: 94°C (20 s), 55°C (30 s), and 72°C (40 s),
with a final extension at 72°C for 5 min. Five microliters of each
PCR product was analyzed by electrophoresis in a 1% agarose gel
stained with ethidium bromide following normalization to an internal
control product amplified in parallel. Relative quantities of each
RT-PCR product amplified from both aerobic and anaerobic RNA were
analyzed by using SigmaGel image analysis software (Jandel Corp., San
Rafael, Calif.). Paired reactions lacking RT were used as negative
controls to detect contamination of RNA by residual genomic DNA.
 |
RESULTS |
RNA isolation.
Cells of E. faecalis MMH594 were
cultured either aerobically or anaerobically to mid-log phase in BHI
broth, isolated, and resuspended in a chaotropic RNA extraction
reagent. Cell lysis was achieved by horizontally shaking the cells
mixed with zirconia-silica beads on a reciprocating high-speed shaking
device, and RNA was isolated as described. RNA was isolated from six
independent aerobic cultures and six independent anaerobic E. faecalis cultures. After electrophoresis, bands indicating the
23S, 16S, and 5S rRNA species were clearly identifiable (data not
shown). Each band was well defined with no smearing, indicating that no
overt degradation of the RNA occurred during isolation. The
A260/A280 ratios ranged from 1.88 to
2.00 for the 12 RNA preparations.
RAP-PCR.
To assess the effect of RNA concentration in RAP-PCR,
various amounts of total RNA (0.125, 0.25, 0.5, 1, and 2 µg) were
used in the first-strand synthesis reactions in a series of
amplifications. For standardization, the same template RNA was used in
each independent amplification. The results of the titration
experiments are shown in Fig. 1. Although
broadly similar from lane to lane, there were RNA-dependent differences
in the number of RAP-PCR products detected. As the amount of RNA in the
first-strand reaction increased from 0.125 to 2 µg, the aggregate
number of RAP-PCR products increased, with a plateau in the number of
well resolved and easily detected products beginning at ca. 1 µg of
RNA in the first-strand reaction. Therefore, 1 µg of RNA was selected
for use in subsequent first-strand reactions.

View larger version (40K):
[in this window]
[in a new window]
|
FIG. 1.
Effects of RNA concentration on RAP-PCR. Different
amounts of the same RNA were amplified by RAP-PCR. In each lane the
following amounts of total RNA were used during first-strand synthesis:
lane 1, 125 ng; lane 2, 250 ng; lane 3, 500 ng; lane 4, 1 µg; and
lane 5, 2 µg. A paired control reaction without RT showed no products
derived from genomic DNA contamination.
|
|
Because RAP-PCR depends on the random priming of an arbitrary primer at
low annealing temperatures, the effect of different annealing
temperatures in the second-strand synthesis reaction was investigated.
A series of annealing reactions was performed with the same template
RNA and a range of temperatures to characterize the impact on the
quantity and quality of the RAP-PCR products generated. The reactions
were performed as described by using 1 µg of template RNA with the
following range of annealing temperatures in the second-strand
synthesis reaction: 20, 25, 30, 36, and 40°C. As the second-strand
annealing temperature increased from 20 to 36°C, the total number of
RAP-PCR products decreased, and the resolution of the larger products
increased (Fig. 2). With interest in
maximizing both the number and the resolution of RAP-PCR products, 36°C was chosen as the second-strand annealing temperature in subsequent reactions.

View larger version (34K):
[in this window]
[in a new window]
|
FIG. 2.
Effects of annealing temperatures during second-strand
synthesis on RAP-PCR. For each reaction, 1 µg of the same total RNA
was amplified by RAP-PCR. In each lane the following annealing
temperatures were used during second-strand synthesis: lane 1, 20°C;
lane 2, 25°C; lane 3, 30°C; lane 4, 36°C; and lane 5, 40°C. A
paired control reaction without RT showed no products derived from
genomic DNA contamination.
|
|
Extended equilibration of the samples during first- and second-strand
synthesis proved to be one of the most important parameters for
achieving reproducibility. Amplification products that resulted from
RAP-PCR amplification of aerobic RNA, either with or without extended
temperature equilibration during first- and second-strand synthesis (5 min at 37°C for the former and 15 min at 36°C for the latter), are
shown in Fig. 3. In lanes 1 to 3, three
aerobic RNA samples were amplified by RAP-PCR without allowing for
extended equilibration of the samples prior to the addition of
appropriate enzymes for DNA synthesis. Thus, RT and Taq
polymerase were added immediately after denaturation. In lanes 4 to 6, the same three aerobic RNA samples were amplified by RAP-PCR as
detailed in the Materials and Methods section. Many of the products
were amplified equivalently regardless of the inclusion or exclusion of
extended equilibration, reflective of favorable priming at certain
sites that did not depend on the stringency of control during first- and second-strand synthesis. However, a more consistent and
reproducible product profile was generated when extended equilibration
was included during amplification. Additionally, there appeared to be a
subtle yet distinct increase in the number of products amplified when
extended equilibration is included.

View larger version (49K):
[in this window]
[in a new window]
|
FIG. 3.
Effects of temperature equilibration during first- and
second-strand synthesis on reproducibility of RAP-PCR amplification.
Total RNA from three independent aerobic cultures of E. faecalis was amplified by RAP-PCR either without (lanes 1 to 3) or
with (lanes 4 to 6) extended equilibration during first- and
second-strand synthesis prior to the addition of the appropriate
enzymes for DNA synthesis. Arrows indicate areas of irreproducibility
in the reactions performed without extended equilibration.
|
|
To assess the reproducibility of the RAP-PCR technique described in the
present work and to determine whether it could be used to identify
differences in enterococcal gene expression, RAP-PCR was performed on
total RNA isolated from aerobically and anaerobically cultured E. faecalis MMH594 by using the optimized reaction parameters.
Aerobiosis was used as a variable to induce potential changes in
enterococcal gene expression. Aerobiosis was chosen as a test variable
because it is significantly different between sites of enterococcal
colonization (e.g., the gastrointestinal tract) and disease (e.g., the
bloodstream). Thus, it may provide an important environmental cue for
regulation of the expression of enterococcal genes. The amplification
products that resulted from RAP-PCR amplification of aerobic and
anaerobic RNA are shown in Fig. 4. To
facilitate discrimination of differentially expressed products from
spurious artifacts and to assess the reproducibility of the optimized
protocol, RAP-PCR was performed with RNA purified from six independent
aerobic and six independent anaerobic E. faecalis cultures.

View larger version (50K):
[in this window]
[in a new window]
|
FIG. 4.
RAP-PCR products derived from samples of total RNA from
aerobically and anaerobically cultured E. faecalis. Lanes: 1 to 6, aerobic samples 1 to 6; 7 to 12, anaerobic samples 1 to 6. Arrows
indicate differentially amplified products. Primer 2 was used for
amplification. For each experimental reaction, a paired negative
control reaction lacking RT during first-strand synthesis was
performed. These controls were used to qualitatively assess the levels
of genomic DNA contamination of each RNA sample. No products derived
from residual genomic DNA contamination were identified in any of the
negative control reactions.
|
|
As expected, a majority of the RAP-PCR products were common to
amplifications of RNA from aerobically and anaerobically cultured E. faecalis (Fig. 4). However, RAP-PCR products that were
unique to either the aerobic or the anaerobic RNA samples could be
identified. Importantly, products unique to RNA derived from either
environment occurred reproducibly. Some RAP-PCR products were amplified
at qualitatively different levels between RNA derived from both
environments, based on variations in the intensities of the bands in
the autoradiograph. The relative amount of a specific product amplified
by RAP-PCR closely parallels the relative amount of the specific
corresponding RNA in a given sample of total RNA (51). Thus,
the intensity of the bands in the autoradiograph can serve as a
qualitative index of the relative abundance of a particular transcript.
Therefore, RAP-PCR appears to provide a sensitive technique for
detecting both gross and subtle differences in gene expression between
populations of E. faecalis.
Sequence identification of differentially expressed RAP-PCR
products.
To identify genes within the emerging E. faecalis genome database that are differentially expressed in
response to changes in oxygen tension, the differentially amplified
RAP-PCR products were recovered and reamplified by standard PCR with
the same arbitrary primer used in RAP-PCR. After reamplification, the
products were gel purified and ligated into a TA cloning vector for
transformation of E. coli. Plasmids were isolated, and the
inserts were subjected to automated sequence analysis. Specific primer
pairs for each RAP-PCR product were designed by using the sequence data
and then used in RT-PCR to confirm differential gene expression (Fig.
5).

View larger version (37K):
[in this window]
[in a new window]
|
FIG. 5.
RT-PCR analysis to confirm differential gene expression.
RT-PCR was performed with both aerobic (A) and anaerobic (An) RNA with
primers specific for each product. Product numbers correspond to those
given in Table 1. Relative quantities of each RT-PCR product amplified
from both aerobic and anaerobic RNA were analyzed after normalization
to the internal control. Paired control reactions lacking RT showed no
products derived from genomic DNA.
|
|
Of 13 total RAP-PCR products amplified with the first application of
the optimized protocol, 4 were identified as false positives for
differential gene expression upon visual examination after RT-PCR with
specific primers (data not shown) and were eliminated from further
analysis. DNA sequence information from the nine RAP-PCR products
confirmed by RT-PCR to be derived from differentially expressed genes
was compared to that in the GenBank database by using the BLAST search
algorithm (49) to identify similarities to known sequences
(Table 1). Cloned inserts of the RAP-PCR
products ranged in size from 181 to 425 bp. Four of the RAP-PCR
products were amplified by using random primer 1, and five were
amplified by using random primer 2. Sequence analysis showed that each
random primer amplified different products, with no duplications either within or between the two groups of products. Additionally, a similar
number of either aerobically or anaerobically induced products were
identified. Sequencing revealed a previously undetected enterococcal
gene that was aerobically induced and exhibited significant similarity
(smallest sum probability score of <10
6) to a
Bacillus subtilis gene coding for catalase (32).
Two aerobically induced products with different sequences had
significant similarity to a B. subtilis gene coding for an
oxidoreductase. Anaerobically induced genes included one with
significant similarity to an ABC transporter from B. subtilis, as well as one with significant similarity to a B. subtilis gene coding for seryl-tRNA synthetase (40).
Two of the anaerobically induced products, both of different sequences,
showed limited similarity (smallest sum probability score of
>10
6) to a mammalian gene coding for NADH dehydrogenase.
Of the RAP-PCR products cloned and sequenced and whose differential
expression was confirmed by RT-PCR, 22% demonstrated no significant
similarity to known sequences.
Data generated by RT-PCR (Fig. 5) was used to quantitate the level to
which genes coding for each RAP-PCR product were specifically induced
(Table 1). RT-PCR products were normalized to an internal control
product identified by RAP-PCR, the expression of which was not affected
by aerobiosis or anaerobiosis. The control product showed significant
similarity (smallest sum probability of 2.2 × 10
56)
to a locus coding for 23S rRNA in Staphylococcus aureus.
After normalization to the non-differentially expressed internal
control, RT-PCR products were visualized by electrophoresis and
analyzed by image analysis to determine relative quantities. For
purposes of calculating the variability of lane-to-lane comparisons,
the four products identified as false positives upon visual examination after RT-PCR were used to determine the standard error of the analysis.
Each of the four products demonstrated relative induction levels of
<1.20 between aerobic and anaerobic RNA samples (data not shown). For
purposes of defining differential gene expression, comparisons
demonstrating differential expression greater than 2 standard
deviations from the mean of these measures (>26% differential expression) were considered significant. The specific level of induction for each of the RAP-PCR products is indicated in Table 1.
RAP-PCR products derived from genes that showed a confirmed, significant difference in expression between an aerobic versus an
anaerobic environment exhibited a broad range of differential expression of 1.56- to 1,029-fold.
 |
DISCUSSION |
In the present study we optimized a technique that has been
applied broadly to analyze patterns of eukaryotic gene expression in
order to permit its reproducible use in studies of gene expression by a
gram-positive bacterium. Initial efforts to use existing protocols for
RAP-PCR in a prokaryotic genetic background (1, 52)
highlighted several extant pitfalls, most notably a lack of
experimental reproducibility. More specifically, we were unable to
generate similar RAP-PCR product patterns upon repeated amplification from either the same RNA sample or the same cDNA sample. Moreover, RAP-PCR amplification of RNA from bacteria cultured independently under
identical conditions yielded widely different product patterns. Therefore, several modifications, which are detailed in the preceding sections, were made to the RAP-PCR protocol that ultimately allowed the
technique to be used in a reproducible manner in the study of
differential enterococcal gene expression. Although the optimized RAP-PCR protocol was optimized while studying differential gene expression in E. faecalis, the same protocol has been used
by others in our laboratory to reproducibly identify products from differentially expressed genes by Streptococcus gordonii and
Actinomyces naeslundii. Additionally, the modifications
included in the optimized RAP-PCR protocol may serve to guide others
who are interested in applying this technology to other bacteria but
who are unable to apply the precise parameters we used.
Of the changes made to previously defined protocols for use of RAP-PCR
to study bacterial genetics, the most significant modifications were
made to the first-strand and second-strand synthesis reactions. Both
steps involve random priming by an arbitrary primer at a low annealing
temperature. We found that extended equilibration of each reaction to
the low annealing temperature prior to the addition of the appropriate
enzyme was essential for achieving reproducibility among similar RNA
samples and upon repeated amplifications of the same sample. Thus,
during first-strand synthesis, each reaction is allowed to equilibrate
to 37°C for 5 min prior to the addition of RT. Similarly, during
second-strand synthesis, each reaction is allowed to equilibrate to
36°C for 15 min prior to the addition of Taq polymerase.
It was not until these subtle yet significant changes were made that
reproducibility in both reactions was achieved. Upon RAP-PCR
amplification with the optimized protocol, each of the six aerobic RNA
preparations produced similar product patterns, as did each of the six
anaerobic RNA preparations (Fig. 4). Thus, there is reproducibility in
RAP-PCR amplification of independent samples of RNA from E. faecalis cultured in a similar manner. Perhaps most importantly,
three independent but identical amplifications of each RNA preparation
yielded identical product patterns (for example, compare Fig. 4, lane
6, with Fig. 1, lane 4, and Fig. 2, lane 4). Thus, there is
reproducibility upon repeated RAP-PCR amplification of a single RNA preparation.
Equilibration to the low annealing temperatures in both first- and
second-strand synthesis prior to the addition of the appropriate enzymes is essential for eliminating the variability inherent to random
priming. For instance, during second-strand synthesis, the RNA-cDNA
duplex is initially denatured. As the reaction is cooled from the
denaturation temperature of 96°C to the low-stringency annealing
temperature of 36°C, it passes through a range of temperatures at
which the random primer can bind. If Taq polymerase were
present in the reaction during this period, polymerization would begin at various points within the temperature ramp. This introduces experimental variability, because the time course of cycling to the low
annealing temperature may be different between independent amplifications of the same sample or between simultaneous
amplifications of independent samples. In standard PCR this variability
is eliminated by using a specific primer at an annealing temperature at
which it must recognize its complement for priming to occur. However, in RAP-PCR such subtle experimental variability is potentiated by using
a random primer at low stringency. Equilibration of each reaction to
36°C prior to the addition of Taq polymerase eliminates this variability. By "clamping" each reaction at the low annealing temperature before synthesis, time is allowed for the primer to recognize all potential binding sites. Thus, each sample is randomly primed essentially to completeness prior to the initiation of polymerization, and polymerization is initiated under identical conditions. The same rationale applies for equilibration of the first-strand synthesis reaction to 37°C prior to the addition of RT.
Using the optimized protocol detailed in the Materials and Methods
section, RAP-PCR was used to identify products from genes differentially expressed when E. faecalis was cultured in an
aerobic versus an anaerobic environment. Additionally, sequence data
generated after RAP-PCR was used to both confirm and quantitate, by
specific RT-PCR, differences in expression for genes coding for the
RAP-PCR products. Several of the RAP-PCR products that were cloned and sequenced demonstrated significant levels of similarity to known sequences in current databases, including several involved in the
respiration of B. subtilis. The role of these genes in
enterococcal biology in either an aerobic or anaerobic environment is
unexplored. However, the data show that the RAP-PCR protocol may be
utilized to reproducibly identify products that derive from
differentially expressed genes and that the RAP-PCR products may
ultimately be used to identify these specific differentially expressed genes.
In the present work, 22% of the RAP-PCR products demonstrated no
similarity to sequences in the databases. Recent sequencing of other
bacterial genomes has demonstrated that many of the inferred proteins
show no homologies to known proteins. For example, 38% of the E. coli K-12 genome (3) and 42% of the Haemophilus
influenzae Rd genome (14) code for proteins with no
known homologies. Similarly, sensitive techniques for the
identification of bacterial genes whose expression is induced by or
within host cells have produced similar data (4, 20, 36,
48). The detection of unique enterococcal genes most likely
reflects gaps in the understanding of E. faecalis genetics
and physiology.
Our current research is directed toward the application of RAP-PCR to
studies of enterococcal gene expression in in vitro and in vivo models
of enterococcal disease. Additionally, we are employing RAP-PCR in
initial studies of gene expression patterns in and among streptococci
and actinomyces and are achieving the same level of reproducibility and
quality. Thus, the refinements detailed in the present work allow the
RAP-PCR protocol to serve as a general and highly reproducible
technique for the study of prokaryotic gene expression.
 |
ACKNOWLEDGMENTS |
This work was supported by NIH grants AI 41108 and EY08289 to
Michael S. Gilmore.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Microbiology and Immunology, University of Oklahoma Health Sciences
Center, 608 Stanton L. Young Blvd., Oklahoma City, OK 73104. Phone:
(405) 271-7969. Fax: (405) 271-3013. E-mail:
mgilmore{at}aardvark.ou.edu.
 |
REFERENCES |
| 1.
|
Abu Kwaik, Y., and L. L. Pederson.
1996.
The use of differential display-PCR to isolate and characterize a Legionella pneumophila locus induced during the intracellular infection of macrophages.
Mol. Microbiol.
21:543-556[Medline].
|
| 2.
|
Bhakdi, S.,
T. Klonisch,
P. Nuber, and W. Fischer.
1991.
Stimulation of monokine production by lipoteichoic acids.
Infect. Immun.
12:4614-4620.
|
| 3.
| Blattner, F. R., et al. The complete genome
sequence of Escherichia coli K-12. Science
277:1452-1462.
|
| 4.
|
Camilli, A., and J. J. Mekalanos.
1995.
Use of recombinase gene fusions to identify Vibrio cholerae genes induced during infection.
Mol. Microbiol.
18:671-683[Medline].
|
| 5.
|
Cheung, A. L.,
K. J. Eberhardt, and V. A. Fischetti.
1994.
A method to isolate RNA from gram-positive bacteria and mycobacteria.
Anal. Biochem.
222:511-514[Medline].
|
| 6.
|
Chow, J. W.,
L. A. Thal,
M. B. Perri,
J. A. Vasquez,
S. M. Donabedian,
D. B. Clewell, and M. J. Zervos.
1993.
Plasmid-encoded hemolysin and aggregation substance production contribute to virulence in experimental enterococcal endocarditis.
Antimicrob. Agents Chemother.
37:2474-2477[Abstract/Free Full Text].
|
| 7.
|
Cummings, N. J., and I. F. Connerton.
1997.
The Bacillus subtilis 168 chromosome from sspE to katA.
Microbiology
143:1855-1859[Medline].
|
| 8.
|
Dunny, G. M.
1990.
Genetic functions and cell-cell interactions in the pheromone-inducible plasmid transfer system of Enterococcus faecalis.
Plasmid
4:689-696.
|
| 9.
|
Eick-Helmerich, K., and V. Braun.
1989.
Import of biopolymers into Escherichia coli: nucleotide sequences of the exbB and exbD genes are homologous to those of the tolQ and tolR genes, respectively.
J. Bacteriol.
171:5117-5126[Abstract/Free Full Text].
|
| 10.
|
Emori, T. G., and R. P. Gaynes.
1993.
An overview of nosocomial infections, including the role of the microbiology laboratory.
Clin. Microbiol. Rev.
6:428-442[Abstract/Free Full Text].
|
| 11.
|
Ena, J.,
R. W. Dick,
R. N. Jones, and R. P. Wenzel.
1993.
The epidemiology of intravenous vancomycin usage in a university hospital: a 10-year study.
JAMA
269:598-602[Abstract].
|
| 12.
|
Evans, A. C., and A. L. Chinn.
1947.
The enterococci: with special reference to their association with human disease.
J. Bacteriol.
54:495-512[Free Full Text].
|
| 13.
|
Fagon, J. Y.,
J. Chastre,
A. Vuagnat,
J. L. Trouillet,
A. Novara, and C. Gibert.
1996.
Nosocomial pneumonia and mortality among patients in intensive care units.
JAMA
275:866-869[Abstract].
|
| 14.
| Fleischmann, R. D., et al. Whole-genome random
sequencing and assembly of Haemophilus influenzae Rd.
Science 269:496-512.
|
| 15.
|
Galli, D.,
F. F. Lottspeich, and R. Wirth.
1990.
Sequence analysis of Enterococcus faecalis aggregation substance encoded by the sex pheromone plasmid pAD1.
Mol. Microbiol.
4:895-904[Medline].
|
| 16.
|
Girou, E., and C. Brun-Buisson.
1996.
Morbidity, mortality, and the cost of nosocomial infections in critical care.
Curr. Opin. Crit. Care
2:347-351.
|
| 17.
|
Gold, H. S., and R. C. Moellering, Jr.
1996.
Antimicrobial-drug resistance.
N. Engl. J. Med.
335:1445-1453[Free Full Text].
|
| 18.
|
Guzmàn, C. A.,
C. Pruzzo,
G. LiPira, and L. Calegari.
1989.
Role of adherence in pathogenesis of Enterococcus faecalis urinary tract infection and endocarditis.
Infect. Immun.
57:1834-1838[Abstract/Free Full Text].
|
| 19.
|
Guzmàn, C. A.,
C. Pruzzo,
M. Platè,
M. C. Guardati, and L. Calegari.
1991.
Serum dependent expression of Enterococcus faecalis adhesins involved in the colonization of heart cells.
Microb. Pathog.
11:399-409[Medline].
|
| 20.
|
Hensel, M.,
J. E. Shea,
C. Gleeson,
M. D. Jones,
E. Dalton, and D. W. Holden.
1995.
Simultaneous identification of bacterial virulence genes by negative selection.
Science
269:400-403[Abstract/Free Full Text].
|
| 21.
|
Huycke, M. M.,
D. F. Sahm, and M. S. Gilmore.
1998.
Multiply resistant enterococci: the nature of the problem and an agenda for the future.
Emerg. Infect. Dis.
4:239-249[Medline].
|
| 22.
|
Huycke, M. M., and M. S. Gilmore.
1995.
Frequency of aggregation substance and cytolysin genes among enterococcal endocarditis isolates.
Plasmid
34:152-156[Medline].
|
| 23.
|
Huycke, M. M.,
C. A. Spiegel, and M. S. Gilmore.
1991.
Bacteremia caused by hemolytic, high-level gentamicin resistant Enterococcus faecalis.
Antimicrob. Agents Chemother.
35:1626-1634[Abstract/Free Full Text].
|
| 24.
|
Ike, Y.,
H. Hashimoto, and D. B. Clewell.
1984.
Hemolysin of Streptococcus faecalis subspecies zymogenes contributes to virulence in mice.
Infect. Immun.
45:528-530[Abstract/Free Full Text].
|
| 25.
|
Jett, B. D.,
M. M. Huycke, and M. S. Gilmore.
1994.
Virulence of enterococci.
Clin. Microbiol. Rev.
7:462-478[Abstract/Free Full Text].
|
| 26.
|
Jett, B. D.,
H. G. Jensen,
R. E. Nordquist, and M. S. Gilmore.
1992.
Contribution of the pAD1-encoded cytolysin to the severity of experimental Enterococcus faecalis endophthalmitis.
Infect. Immun.
60:2445-2452[Abstract/Free Full Text].
|
| 27.
|
Kaye, D.
1982.
Enterococci: biologic and epidemiologic characteristics and in vitro susceptibility.
Arch. Intern. Med.
142:2006-2009[Medline].
|
| 28.
|
Kreft, B.,
R. Marre,
U. Schramm, and R. Wirth.
1992.
Aggregation substance of Enterococcus faecalis mediates adhesion to cultured renal tubular cells.
Infect. Immun.
60:25-30[Abstract/Free Full Text].
|
| 29.
|
Leclercq, R.,
E. Derlot,
J. Duval, and P. Courvalin.
1988.
Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium.
N. Engl. J. Med.
319:157-161[Medline].
|
| 30.
|
Liang, P.,
L. Averboukh, and A. B. Pardee.
1993.
Distribution and cloning of eukaryotic mRNAs by means of differential display: refinements and optimization.
Nucleic Acids Res.
21:3269-3275[Abstract/Free Full Text].
|
| 31.
|
Liang, P., and A. B. Pardee.
1992.
Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction.
Science
257:967-971[Abstract/Free Full Text].
|
| 32.
|
Loewen, P. C., and J. Switala.
1987.
Multiple catalases in Bacillus subtilis.
J. Bacteriol.
169:3601-3607[Abstract/Free Full Text].
|
| 33.
|
MacCallum, W. G., and T. W. Hastings.
1899.
A case of acute endocarditis caused by Micrococcus zymogenes (nov. spec.), with a description of the organism.
J. Exp. Med.
4:521-534.
|
| 34.
|
Maki, D. G., and W. A. Agger.
1988.
Enterococcal bacteremia: clinical features, the risk of endocarditis, and management.
Medicine (Baltimore)
67:248-269[Medline].
|
| 35.
|
McClelland, M.,
F. Mathieu-Daude, and J. Welsh.
1995.
RNA fingerprinting and differential display using arbitrarily primed PCR.
Trends Genet.
11:242-246[Medline].
|
| 36.
| Mei, J.-M., F. Nourbakhsh, C. W. Ford,
and D. W. Holden. Identification of Staphylococcus
aureus virulence genes in a murine model of bacteraemia using
signature-tagged mutagenesis. Mol. Microbiol. 26:399-407.
|
| 37.
|
Moellering, R. C., Jr.
1992.
Emergence of enterococcus as a significant pathogen.
Clin. Infect. Dis.
14:1173-1178[Medline].
|
| 38.
|
National Nosocomial Infections Surveillance System.
1997.
National nosocomial infections surveillance (NNIS) report, data summary from October 1986-April 1997, issued May 1997.
Am. J. Infect. Control
25:477-487[Medline].
|
| 39.
|
Nichols, R. L., and A. C. Muzik.
1992.
Enterococcal infections in surgical patients: the mystery continues.
Clin. Infect. Dis.
15:72-76[Medline].
|
| 40.
|
Ogasawara, N.,
S. Nakai, and H. Yoshikawa.
1994.
Systematic sequencing of the 180 kilobase region of the Bacillus subtilis chromosome containing the replication origin.
DNA Res.
1:1-14[Abstract/Free Full Text].
|
| 41.
|
Rantz, L. A., and W. M. K. Kirby.
1943.
Enterococcic infections: an evaluation of the importance of fecal streptococci and related organisms in the causation of human disease.
Arch. Intern. Med.
71:516-528[Abstract/Free Full Text].
|
| 42.
|
Ruoff, K. L.,
L. De La Maza,
M. J. Murtagh,
J. D. Spargo, and M. J. Ferraro.
1990.
Species identities of enterococi isolated from clinical specimens.
J. Clin. Microbiol.
28:435-437[Abstract/Free Full Text].
|
| 43.
|
Sambrook, J.,
E. F. Fritsch, and T. Maniatis.
1989.
Molecular cloning: a laboratory manual, 2nd ed.
Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
|
| 44.
|
Schaberg, D. R.,
D. H. Culver, and R. P. Gaynes.
1991.
Major trends in the microbial etiology of nosocomial infection.
Am. J. Med.
91(Suppl. 3B):72S-75S[Medline].
|
| 45.
|
Schlievert, P. M.,
P. J. Gahr,
A. P. Assimacopoulos,
M. M. Dinges,
J. A. Stoehr,
J. W. Harmala,
H. Hirt, and G. M. Dunny.
1998.
Aggregation and binding substances enhance pathogenicity in rabbit models of Enterococcus faecalis endocarditis.
Infect. Immun.
66:218-223[Abstract/Free Full Text].
|
| 46.
|
Schutte, B. C.,
K. Ranade,
J. Pruessner, and N. Dracopoli.
1997.
Optimized conditions for cloning PCR products into an XcmI T-vector.
BioTechniques
22:40-44[Medline].
|
| 47.
|
Uttley, A. H.,
C. H. Collins,
J. Naidoo, and R. C. George.
1988.
Vancomycin-resistant enterococci.
Lancet
1:57-58[Medline]. (Letter.)
|
| 48.
| Valdivia, R. H., and S. Falkow.
Fluorescence-based isolation of bacterial genes expressed within host
cells. Science 277:2007-2011.
|
| 49.
|
Warren, G., and D. J. States.
1993.
Identification of protein coding regions by database similarity search.
Nat. Genet.
3:266-272[Medline].
|
| 50.
|
Wells, C. L., and S. L. Erlandsen.
1991.
Localization of translocating Escherichia coli, Proteus mirabilis, and Enterococcus faecalis within cecal and colonic tissues of monoassociated mice.
Infect. Immun.
59:4693-4697[Abstract/Free Full Text].
|
| 51.
|
Welsh, J.,
K. Chada,
S. S. Dalal,
R. Cheng,
D. Ralph, and M. McClelland.
1992.
Arbitrarily primed PCR fingerprinting of RNA.
Nucleic Acids Res.
20:4965-4970[Abstract/Free Full Text].
|
| 52.
|
Wong, K. K., and M. McClelland.
1994.
Stress-inducible gene of Salmonella typhimurium identified by arbitrarily primed PCR of RNA.
Proc. Natl. Acad. Sci. USA
91:639-643[Abstract/Free Full Text].
|
Applied and Environmental Microbiology, April 1999, p. 1470-1476, Vol. 65, No. 4
0099-2240/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Coburn, P. S., Baghdayan, A. S., Dolan, G., Shankar, N.
(2008). An AraC-Type Transcriptional Regulator Encoded on the Enterococcus faecalis Pathogenicity Island Contributes to Pathogenesis and Intracellular Macrophage Survival. Infect. Immun.
76: 5668-5676
[Abstract]
[Full Text]
-
Papadimitriou, K., Boutou, E., Zoumpopoulou, G., Tarantilis, P. A., Polissiou, M., Vorgias, C. E., Tsakalidou, E.
(2008). RNA Arbitrarily Primed PCR and Fourier Transform Infrared Spectroscopy Reveal Plasticity in the Acid Tolerance Response of Streptococcus macedonicus. Appl. Environ. Microbiol.
74: 6068-6076
[Abstract]
[Full Text]
-
De Long, S. K., Kinney, K. A., Kirisits, M. J.
(2008). Prokaryotic Suppression Subtractive Hybridization PCR cDNA Subtraction, a Targeted Method To Identify Differentially Expressed Genes. Appl. Environ. Microbiol.
74: 225-232
[Abstract]
[Full Text]
-
Le Breton, Y., Muller, C., Auffray, Y., Rince, A.
(2007). New Insights into the Enterococcus faecalis CroRS Two-Component System Obtained Using a Differential-Display Random Arbitrarily Primed PCR Approach. Appl. Environ. Microbiol.
73: 3738-3741
[Abstract]
[Full Text]
-
Van Wamel, W. J. B., Hendrickx, A. P. A., Bonten, M. J. M., Top, J., Posthuma, G., Willems, R. J. L.
(2007). Growth Condition-Dependent Esp Expression by Enterococcus faecium Affects Initial Adherence and Biofilm Formation. Infect. Immun.
75: 924-931
[Abstract]
[Full Text]
-
Stelzer, S., Egan, S., Larsen, M. R., Bartlett, D. H., Kjelleberg, S.
(2006). Unravelling the role of the ToxR-like transcriptional regulator WmpR in the marine antifouling bacterium Pseudoalteromonas tunicata.. Microbiology
152: 1385-1394
[Abstract]
[Full Text]
-
Tendolkar, P. M., Baghdayan, A. S., Shankar, N.
(2006). Putative Surface Proteins Encoded within a Novel Transferable Locus Confer a High-Biofilm Phenotype to Enterococcus faecalis. J. Bacteriol.
188: 2063-2072
[Abstract]
[Full Text]
-
Frias-Lopez, J., Bonheyo, G. T., Fouke, B. W.
(2004). Identification of Differential Gene Expression in Bacteria Associated with Coral Black Band Disease by Using RNA-Arbitrarily Primed PCR. Appl. Environ. Microbiol.
70: 3687-3694
[Abstract]
[Full Text]
-
Chang, I. S., Groh, J. L., Ramsey, M. M., Ballard, J. D., Krumholz, L. R.
(2004). Differential Expression of Desulfovibrio vulgaris Genes in Response to Cu(II) and Hg(II) Toxicity. Appl. Environ. Microbiol.
70: 1847-1851
[Abstract]
[Full Text]
-
Gilmore, K. S., Srinivas, P., Akins, D. R., Hatter, K. L., Gilmore, M. S.
(2003). Growth, Development, and Gene Expression in a Persistent Streptococcus gordonii Biofilm. Infect. Immun.
71: 4759-4766
[Abstract]
[Full Text]
-
Hancock, L. E., Shepard, B. D., Gilmore, M. S.
(2003). Molecular Analysis of the Enterococcus faecalis Serotype 2 Polysaccharide Determinant. J. Bacteriol.
185: 4393-4401
[Abstract]
[Full Text]
-
Frankenberg, L., Brugna, M., Hederstedt, L.
(2002). Enterococcus faecalis Heme-Dependent Catalase. J. Bacteriol.
184: 6351-6356
[Abstract]
[Full Text]
-
Shepard, B. D., Gilmore, M. S.
(2002). Differential Expression of Virulence-Related Genes in Enterococcus faecalis in Response to Biological Cues in Serum and Urine. Infect. Immun.
70: 4344-4352
[Abstract]
[Full Text]
-
Steger, J. L., Vincent, C., Ballard, J. D., Krumholz, L. R.
(2002). Desulfovibrio sp. Genes Involved in the Respiration of Sulfate during Metabolism of Hydrogen and Lactate. Appl. Environ. Microbiol.
68: 1932-1937
[Abstract]
[Full Text]
-
Hanna, M. N., Ferguson, R. J., Li, Y.-H., Cvitkovitch, D. G.
(2001). uvrA Is an Acid-Inducible Gene Involved in the Adaptive Response to Low pH in Streptococcus mutans. J. Bacteriol.
183: 5964-5973
[Abstract]
[Full Text]
-
Du, L. D., Kolenbrander, P. E.
(2000). Identification of Saliva-Regulated Genes of Streptococcus gordonii DL1 by Differential Display Using Random Arbitrarily Primed PCR. Infect. Immun.
68: 4834-4837
[Abstract]
[Full Text]
-
Gravesen, A., Warthoe, P., Knøchel, S., Thirstrup, K.
(2000). Restriction fragment differential display of pediocin-resistant Listeria monocytogenes 412 mutants shows consistent overexpression of a putative {beta}-glucoside-specific PTS system. Microbiology
146: 1381-1389
[Abstract]
[Full Text]
-
Coburn, P. S., Hancock, L. E., Booth, M. C., Gilmore, M. S.
(1999). A Novel Means of Self-Protection, Unrelated to Toxin Activation, Confers Immunity to the Bactericidal Effects of the Enterococcus faecalis Cytolysin. Infect. Immun.
67: 3339-3347
[Abstract]
[Full Text]